Amgen Inc.

🇺🇸NASDAQ Global Select
Back to all articles
Amgen Inc. stock analysis AMGN overview
Neutral 0

Are Options Traders Betting on a Big Move in Amgen Stock?

📊 Options traders are pricing in significant movement for Amgen Inc. (AMGN) stock, indicated by the May 15, 2026 $200 Call option having among the highest implied volatility levels today.

📉 High implied volatility typically suggests investors anticipate a substantial price change due to upcoming events or fundamental shifts in one direction.

🏥 Currently, Amgen holds a Zacks Rank #3 (Hold) within the Medical - Biomedical and Genetics industry, placing it in the Bottom 40% of its industry rank.

📝 Analyst sentiment is mixed regarding earnings estimates for the current quarter; one analyst increased their projection while five reduced theirs.

💰 The net impact of these changes lowered the Zacks Consensus Estimate for the current quarter from $5.81 per share to $5.64 per share.

💸 Experienced options traders often seek high implied volatility opportunities to sell premium and capture time decay rather than betting on a price increase.

⚠️ The strategy of selling options relies on the underlying stock not moving as much as originally expected by expiration.

📰 This analysis originates from Zacks Investment Research, which offers additional reports including "7 Best Stocks for the Next 30 Days" and free stock analysis reports for Amgen.

Bullish Signals
  • Options traders are pricing in significant future movement for Amgen, potentially indicating upcoming positive catalysts that could drive a rally.
  • One analyst recently increased earnings estimates for the current quarter, suggesting some market optimism remains.
  • Amgen has been recognized in Zacks Investment Research's report of '7 Best Stocks for the Next 30 Days', highlighting its potential inclusion among top investment opportunities.
Risk Factors
  • Amgen is currently ranked as a Zacks Rank #3 (Hold) and sits within the Bottom 40% of its Medical - Biomedical and Genetics industry, indicating weak relative performance.
  • Analyst sentiment has turned negative with five analysts dropping their earnings estimates versus only one increase over the last 30 days.
  • The revised Zacks Consensus Estimate for the current quarter has fallen from $5.81 per share to $5.64, reflecting diminished profit expectations.
Full Analysis
Amgen Inc. (AMGN) is experiencing heightened activity in the options market, specifically with the May 15, 2026 $200 Call option showing elevated implied volatility compared to other equity options currently trading. High implied volatility indicates that traders are anticipating a significant price movement in either direction, which often suggests upcoming events or uncertainty regarding the company's future performance. While this metric signals potential volatility, it is noted as only one component of an options strategy and does not confirm the direction of the move. Fundamentally, the outlook for Amgen appears cautious according to recent analyst adjustments. The company currently holds a Zacks Rank #3 (Hold) and sits in the bottom 40% of its Medical - Biomedical and Genetics industry rank based on Zacks metrics. Over the past 30 days, sentiment has cooled as five analysts have lowered their earnings estimates for the current quarter, while only one analyst raised theirs. Consequently, the Zacks Consensus Estimate for earnings per share has been revised downward from $5.81 to $5.64. The disparity between the high options activity and the negative fundamental revision suggests a possible divergence in strategy among market participants. Traders purchasing these high-volatility calls may be seeking a specific catalyst, whereas seasoned options traders might interpret the high volatility as an opportunity to sell premium and profit from time decay if the stock does not move significantly before expiration. This dynamic implies that while investors are pricing in uncertainty or a potential rally, analyst consensus leans towards holding rather than buying, suggesting caution regarding earnings expectations for the current quarter.